phosphatidylcholine (22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))

Term ID

CHEBI:142700

Synonyms

(2R)-3-[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyloxy]-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]propyl 2-(trimethylammonio)ethyl phosphate
1-(7Z,10Z,13Z,16Z-docosatetraenoyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholine
PC(22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
PC(22:4/20:4)

Definition

A phosphatidylcholine (22:4/20:4) which carries a (6Z,9Z,12Z,15Z)-22-oxodocosa-6,9,12,15-tetraen-22-yl group at position 1 and a (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl group at position 2.

References

HMDB:HMDB0008640
LIPID_MAPS_instance:LMGP01012089

Ontology

ChEBI ( EBI )

Relationships

is a type of: phosphatidylcholine (22:4/20:4)

phosphatidylcholine (22:4/20:4) Show first 5 Terms

Phenotype

Phenotype resulting from phosphatidylcholine (22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))

Phenotype where environments contain phosphatidylcholine (22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))

Phenotype modified by environments containing phosphatidylcholine (22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))

Human Disease Model